Reply

Ann C. Wu; A. David Paltiel; Karen M. Kuntz; Scott T. Weiss; Anne L. Fuhlbrigge

doi:10.1016/j.jaci.2008.01.073

Reply

Ann C. Wu, A. David Paltiel, Karen M. Kuntz, Scott T. Weiss, Anne L. Fuhlbrigge

Health Policy and Management

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	1514-1515
Number of pages	2
Journal	Journal of Allergy and Clinical Immunology
Volume	121
Issue number	6
DOIs	https://doi.org/10.1016/j.jaci.2008.01.073
State	Published - Jun 2008

Bibliographical note

Funding Information:
Supported by the National Heart, Lung, and Blood Institute through grant R01 HL68201-01A1.

Funding Information:
Disclosure of potential conflict of interest: A. D. Paltiel has received research support from the National Institutes of Health. S. T. Weiss has received research support from the National Institutes of Health and Genentech. A. L. Fuhlbrigge is on the speakers' bureau for GlaxoSmithKline and Merck, designed and analyzed studies for Novartis, was a member of Sepracor's Data Safety Monitoring Board, and has received research support from Boehringer Ingelheim, GlaxoSmithKline, and Merck. The rest of the authors have declared that they have no conflict of interest.

Access

10.1016/j.jaci.2008.01.073

Cite this

@article{04b61ef53f1a43a28cc6635e61bb577f,

title = "Reply",

author = "Wu, {Ann C.} and Paltiel, {A. David} and Kuntz, {Karen M.} and Weiss, {Scott T.} and Fuhlbrigge, {Anne L.}",

note = "Funding Information: Supported by the National Heart, Lung, and Blood Institute through grant R01 HL68201-01A1. Funding Information: Disclosure of potential conflict of interest: A. D. Paltiel has received research support from the National Institutes of Health. S. T. Weiss has received research support from the National Institutes of Health and Genentech. A. L. Fuhlbrigge is on the speakers' bureau for GlaxoSmithKline and Merck, designed and analyzed studies for Novartis, was a member of Sepracor's Data Safety Monitoring Board, and has received research support from Boehringer Ingelheim, GlaxoSmithKline, and Merck. The rest of the authors have declared that they have no conflict of interest. ",

year = "2008",

month = jun,

doi = "10.1016/j.jaci.2008.01.073",

language = "English (US)",

volume = "121",

pages = "1514--1515",

journal = "Journal of Allergy and Clinical Immunology",

issn = "0091-6749",

publisher = "Mosby Inc.",

number = "6",

}

TY - JOUR

T1 - Reply

AU - Wu, Ann C.

AU - Paltiel, A. David

AU - Kuntz, Karen M.

AU - Weiss, Scott T.

AU - Fuhlbrigge, Anne L.

N1 - Funding Information: Supported by the National Heart, Lung, and Blood Institute through grant R01 HL68201-01A1. Funding Information: Disclosure of potential conflict of interest: A. D. Paltiel has received research support from the National Institutes of Health. S. T. Weiss has received research support from the National Institutes of Health and Genentech. A. L. Fuhlbrigge is on the speakers' bureau for GlaxoSmithKline and Merck, designed and analyzed studies for Novartis, was a member of Sepracor's Data Safety Monitoring Board, and has received research support from Boehringer Ingelheim, GlaxoSmithKline, and Merck. The rest of the authors have declared that they have no conflict of interest.

PY - 2008/6

Y1 - 2008/6

UR - http://www.scopus.com/inward/record.url?scp=44649123258&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44649123258&partnerID=8YFLogxK

U2 - 10.1016/j.jaci.2008.01.073

DO - 10.1016/j.jaci.2008.01.073

M3 - Letter

AN - SCOPUS:44649123258

VL - 121

SP - 1514

EP - 1515

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

SN - 0091-6749

IS - 6

ER -

Reply

Bibliographical note

Access

Other files and links

Cite this